ECSP982591A - NEW METHOD OF TREATMENT IV - Google Patents
NEW METHOD OF TREATMENT IVInfo
- Publication number
- ECSP982591A ECSP982591A ECSP982591A ECSP982591A EC SP982591 A ECSP982591 A EC SP982591A EC SP982591 A ECSP982591 A EC SP982591A EC SP982591 A ECSP982591 A EC SP982591A
- Authority
- EC
- Ecuador
- Prior art keywords
- treatment
- new method
- mammal
- diabetes mellitus
- insulin
- Prior art date
Links
- 241000124008 Mammalia Species 0.000 abstract 2
- 206010012601 diabetes mellitus Diseases 0.000 abstract 2
- XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 abstract 1
- 229940123208 Biguanide Drugs 0.000 abstract 1
- 229940122199 Insulin secretagogue Drugs 0.000 abstract 1
- 229940122355 Insulin sensitizer Drugs 0.000 abstract 1
- 239000003472 antidiabetic agent Substances 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Un método para el tratamiento de la diabetes mellitus y las condiciones asociadas con la diabetes mellitus en un mamífero, método que comprende administrar una cantidad efectiva, no tóxica y farmacéuticamente aceptable de un sensibilizador de insulina, un secretagogo de insulina y un agente antihiperglucémico del tipo biguanida, a un mamífero que lo necesite, y una composición para empleo en dicho método.A method for the treatment of diabetes mellitus and the conditions associated with diabetes mellitus in a mammal, which method comprises administering an effective, non-toxic and pharmaceutically acceptable amount of an insulin sensitizer, an insulin secretagogue and an antihyperglycemic agent of the type biguanide, to a mammal in need, and a composition for use in said method.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982591 ECSP982591A (en) | 1998-07-16 | 1998-07-16 | NEW METHOD OF TREATMENT IV |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982591 ECSP982591A (en) | 1998-07-16 | 1998-07-16 | NEW METHOD OF TREATMENT IV |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP982591A true ECSP982591A (en) | 1999-02-22 |
Family
ID=42043511
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP982591 ECSP982591A (en) | 1998-07-16 | 1998-07-16 | NEW METHOD OF TREATMENT IV |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP982591A (en) |
-
1998
- 1998-07-16 EC ECSP982591 patent/ECSP982591A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP024397A (en) | COMBINATIONS OF DIPEPTILDIL PEPTIDASA IV INIHIBITORS AND OTHER ANTI-DIABETIC AGENTS FOR THE TREATMENT OF MELLITUS DIABETES | |
| UY25799A1 (en) | PHARMACEUTICAL COMPOSITION OF MODIFIED RELEASE INCLUDING AN INSULIN SENSITIZER AND ANOTHER ANTI-DIABETIC AGENT. | |
| NO20090846L (en) | Combination and pharmaceutical composition for the treatment of diabetes and its use | |
| MY155219A (en) | Treatment of diabetes with thiazolidinedione, insulin secretagogue and biguanide | |
| UY25798A1 (en) | PHARMACEUTICAL COMPOSITION OF MODIFIED RELEASE INCLUDING A THIAZOLIDINADIONIC INSULIN SENSITIZER. | |
| CO4940454A1 (en) | NEW METHOD OF TREATMENT | |
| AR019724A2 (en) | PHARMACEUTICAL COMPOSITION USEFUL FOR THE TREATMENT OF MELLITUS DIABETES AND ASSOCIATED CONDITIONS | |
| UY25103A1 (en) | COMPOSITION FOR THE TREATMENT OF DIABETES MELLITUS | |
| AR013352A1 (en) | USE OF AN INSULIN SENSITIZER AND AN ANTI-HYPERGLYCEMIC AGENT FOR THE PREPARATION OF A MEDICATION FOR THE TREATMENT OF DIABETES MELLITUS AND CONDITIONS ASSOCIATED WITH IT AND A PHARMACEUTICAL COMPOSITION. | |
| AR008025A1 (en) | PHARMACEUTICAL COMBINATION OF A THIAZOLIDINDIONA AND AN INSULIN SECRETOGOGUE | |
| ECSP982591A (en) | NEW METHOD OF TREATMENT IV | |
| HK1041201A1 (en) | Compatibility of beta agonists and antidiabetic agents | |
| ECSP982535A (en) | NEW TREATMENT METHOD (I) | |
| ECSP982541A (en) | NEW METHOD OF TREATMENT II | |
| ECSP982592A (en) | NEW METHOD OF TREATMENT V | |
| ECSP982593A (en) | NEW METHOD OF TREATMENT VI | |
| CO5150158A1 (en) | NEW ANTIDIABETIC TREATMENT | |
| CO5270004A1 (en) | PHARMACEUTICAL COMPOSITIONS WITH BIGUANIDA TYPE AGENT FOR DIABETES TREATMENTS | |
| WO2001047509A3 (en) | Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions | |
| ECSP982542A (en) | NEW METHOD OF TREATMENT III | |
| UY29531A1 (en) | THIAZOLIDINEDIONA AND METFORMIN COMPOUNDS FOR THE TREATMENT OF DIABETES | |
| ECSP982534A (en) | NEW METHOD OF TREATMENT | |
| UY26341A1 (en) | METHOD FOR THE TREATMENT OF METABOLIC DISORDERS, ESPECIALLY DIABETES, OR A DISEASE OR CONDITION ASSOCIATED WITH DIABETES. | |
| ECSP993217A (en) | NEW TREATMENT METHOD VII |